Gastric cancer (GC) ranks fifth in global cancer diagnosis and fourth in cancer-related death.
Despite tremendous progress in diagnosis and therapeutic strategies and significant …

Despite its decreasing incidence, gastric cancer remains an important global healthcare
problem due to its overall high prevalence and high mortality rate. Since the MAGIC and …

Exosomal transfer of oncogenic miRNAs can enhance recipient cell growth, metastasis and
chemoresistance. Currently we found that microRNA-501-5p (miR-501) was overexpressed …

Gastric cancer (GC) is the fifth-most common cancer worldwide and an important cause of
cancer-related-death. The growing knowledge of its molecular pathogenesis has shown that …

Background We aimed to identify novel tumor-promoting drivers highly expressed in gastric
cancer (GC) that contribute to worsened prognosis in affected patients. Methods Genes …

Infection with Helicobacter pylori, a Gram-negative, microaerophilic pathogen often results in
gastric cancer in a subset of affected individuals. This explains why H. pylori is the only …

Gastric cancer (GC) pathogenesis is complex and heterogeneous, reflecting morphological,
molecular and genetic diversity. Diffuse gastric cancer (DGC) and intestinal gastric cancer …

Purpose Macrophages are a major component of the tumour microenvironment and play an
important role in chemoresistance of cancer. However, how exosomal microRNAs (miRNAs) …

Multimodality treatment represents the standard of care for resectable gastric cancer.
Perioperative chemotherapy with FLOT is the standard treatment in western countries; in …

Gastric cancer is the fourth most common cancer and the second most frequent cause of
cancer death worldwide. Chemotherapy is an important treatment. However, traditional …